Morgan Stanley Collegium Pharmaceutical, Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Morgan Stanley holds 611,731 shares of COLL stock, worth $19.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

611,731

Previous 631,082 3.07%

Holding current value

$19.9 Million

Previous $20.3 Million 16.32%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$31.4 - $39.07 $607,621 - $756,043	-19,351 Reduced 3.07%	611,731 $23.6 Million
Q2 2024 Oct 17, 2024	SELL	$31.36 - $39.99 $6.46 Million - $8.23 Million	-205,862 Reduced 24.6%	631,082 $20.3 Million
Q2 2024 Aug 14, 2024	SELL	$31.36 - $39.99 $6.46 Million - $8.23 Million	-205,862 Reduced 24.6%	631,082 $20.3 Million
Q1 2024 Oct 17, 2024	BUY	$31.23 - $40.91 $6.43 Million - $8.42 Million	205,862 Added 32.62%	836,944 $32.5 Million
Q1 2024 Aug 16, 2024	SELL	$31.23 - $40.91 $5.15 Million - $6.74 Million	-164,807 Reduced 16.45%	836,944 $32.5 Million
Q1 2024 May 15, 2024	SELL	$31.23 - $40.91 $5.15 Million - $6.74 Million	-164,807 Reduced 16.45%	836,944 $32.5 Million
Q4 2023 Aug 16, 2024	BUY	$21.16 - $30.8 $7.84 Million - $11.4 Million	370,669 Added 58.74%	1,001,751 $30.8 Million
Q4 2023 Feb 13, 2024	BUY	$21.16 - $30.8 $8.75 Million - $12.7 Million	413,286 Added 70.23%	1,001,751 $30.8 Million
Q3 2023 Nov 15, 2023	BUY	$21.23 - $24.28 $847,544 - $969,306	39,922 Added 7.28%	588,465 $13.2 Million
Q2 2023 Aug 14, 2023	SELL	$21.06 - $24.0 $1.47 Million - $1.68 Million	-69,814 Reduced 11.29%	548,543 $11.8 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $5.74 Million - $7.45 Million	249,484 Added 67.63%	618,357 $14.8 Million
Q4 2022 Feb 14, 2023	SELL	$16.14 - $23.55 $745,151 - $1.09 Million	-46,168 Reduced 11.12%	368,873 $8.56 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $594,916 - $773,468	38,481 Added 10.22%	415,041 $6.65 Million
Q2 2022 Oct 27, 2022	BUY	$14.22 - $20.88 $159,690 - $234,482	11,230 Added 3.07%	376,560 $6.67 Million
Q2 2022 Aug 15, 2022	BUY	$14.22 - $20.88 $159,690 - $234,482	11,230 Added 3.07%	376,560 $6.67 Million
Q1 2022 Oct 27, 2022	SELL	$17.2 - $22.5 $193,156 - $252,675	-11,230 Reduced 2.98%	365,330 $7.44 Million
Q1 2022 May 13, 2022	BUY	$17.2 - $22.5 $2.95 Million - $3.86 Million	171,706 Added 88.68%	365,330 $7.44 Million
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $424,777 - $518,228	24,273 Added 14.33%	193,624 $3.62 Million
Q3 2021 Nov 15, 2021	BUY	$17.75 - $25.39 $3.01 Million - $4.3 Million	169,351 New	169,351 $3.34 Million

Others Institutions Holding COLL

# of Institutions

249

Shares Held

36.2M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account